IL3 and chronic myelogenous leukemia, BCR-ABL1 positive: Similarly, in another study, engineered EVs were synthesized derived from HEK293T cells expressing Lamp2b conjugated with IL-3 fragments for the treatment of chronic myeloid leukaemia (CML) (88).